Wyeth, GSK Vaccines May Get Sales Boost Under Pilot For Developing Countries

Pediatric pneumococcal vaccines in development by Wyeth and GlaxoSmithKline could be the first products to benefit from a pilot program designed to create an incentive to develop vaccines that treat the diseases of the developing world